Early cardiovascular disease markers in "healthy" OSA patients are correlated with sympathetic activity

D. Lacedonia, R. Tamisier, J. P. Baguet, J. L. Pepin, P. Levy (La Tronche, Grenoble, France; Foggia, Italy)

Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain
Session: Obstructive sleep apnoea: the heart and the brain
Session type: Poster Discussion
Number: 1754
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Lacedonia, R. Tamisier, J. P. Baguet, J. L. Pepin, P. Levy (La Tronche, Grenoble, France; Foggia, Italy). Early cardiovascular disease markers in "healthy" OSA patients are correlated with sympathetic activity. Eur Respir J 2011; 38: Suppl. 55, 1754

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Do nocturnal apnoeas contribute to increased cardiovascular risk in end stage renal disease patients?
Source: Annual Congress 2008 - Weight control and comorbidity in obstructive sleep apnoea
Year: 2008

Evaluation for patients‘ characteristics and related factors correlated with subclinical peripheral nerves deficit in stable COPD patients
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009


Early signs of cardiovascular system dysfunction in obstructive sleep apnea (OSA) patients before clinical manifestation
Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea
Year: 2009

Markers of cardiovascular autonomic dysfunction predict COPD in middle-aged subjects
Source: Eur Respir J, 51 (3) 1702481; 10.1183/13993003.02481-2017
Year: 2018



Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019

Presence of cardiovascular risk markers in OSAS
Source: Annual Congress 2007 - Systemic effects of obstructive sleep apnoea
Year: 2007


The risk of future cardiovascular diseases in the patients with OSAS is dependently or independently associated with obstructive sleep apnoea
Source: Eur Respir J 2001; 17: 573-574
Year: 2001


Relationship between lung function disorders and condition of cardiovascular system in patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 422s
Year: 2003

Study of heart rate autonomic modulation in patients with asthma disease
Source: Annual Congress 2011 - Asthma: issues in rehabilitation and physical therapy
Year: 2011

A study on the association between the severity of newly diagnosed obstructive sleep apnea and subclinical carotid atherosclerosis in patients without overt cardiovascular disease
Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea
Year: 2016

Renal function impairment and prediction of sleep apnea in patients with high cardiovascular risk
Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification
Year: 2020


Relationship between NT-proBNP level, echocardiographic parameters and cardiovascular diseases in patients with obstructive sleep apnoea (OSA)
Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA
Year: 2012


The cut-off value of physical activity associated with mortality in patients with chronic obstructive pulmonary disease
Source: International Congress 2019 – Breathing, posture and physical activity in respiratory disease patients
Year: 2019


Physical activity in obstructive sleep apnea (OSA) patients with high cardiovascular risk
Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise
Year: 2010


Increased heart rate modulation, sympathetic dominance and systemic inflammation in chronic obstructive pulmonary disease
Source: International Congress 2014 – Markers
Year: 2014

Leukocytosis as a marker of chronic inflammation and early cardiovascular risk in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2007; 30: Suppl. 51, 593s
Year: 2007

Sympathetic activation in COPD as a link to cardiovascular disease
Source: Annual Congress 2011 - Knowing COPD by heart: a relationship beyond comorbidity
Year: 2011

Early peripheral muscle structural and metabolic impairment in chronic obstructive pulmonary disease (COPD) patients cannot be considered as a consequence of sedentarity
Source: Annual Congress 2011 - Skeletal muscle weakness in COPD: physical (in)activity and biological markers
Year: 2011


Assessment of aortic stiffness which is a new cardiovascular morbidity and mortality predictor in patients with obstructive sleep apnea syndrome and relation with severity of the disease
Source: Eur Respir J 2006; 28: Suppl. 50, 814s
Year: 2006

Relationship between plasma NT-proBNP level and cardiovascular complications in obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease
Year: 2010